(Q39238164)

10 September 2017

title

Engineering of Escherichia coli strains for plasmid biopharmaceutical production: scale-up challenges (English)

1 reference

10 September 2017

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598722%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Duarte Miguel F Prazeres

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598722%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Geisa A L Gonçalves

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598722%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Kristala L J Prather

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598722%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

2 March 2014

1 reference

10 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598722%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598722%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598722%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

2847-2850

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598722%20AND%20SRC:MED&resulttype=core&format=json

Immunologic responses to West Nile virus in vaccinated and clinically affected horses

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Efficacy of an infectious hematopoietic necrosis (IHN) virus DNA vaccine in Chinook Oncorhynchus tshawytscha and sockeye O. nerka salmon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Growth hormone-releasing hormone plasmid treatment by electroporation decreases offspring mortality over three pregnancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Plasmid DNA fermentation strain and process-specific effects on vector yield, quality, and transgene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Development of new plasmid DNA vaccine vectors with R1-based replicons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Electroporation delivery of DNA vaccines: prospects for success

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Pyruvate kinase-deficient Escherichia coli exhibits increased plasmid copy number and cyclic AMP levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

De novo creation of MG1655-derived E. coli strains specifically designed for plasmid DNA production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Host strain influences on supercoiled plasmid DNA production in Escherichia coli: Implications for efficient design of large-scale processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

The impact of polyadenylation signals on plasmid nuclease-resistance and transgene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Assessment of purity and quantification of plasmid DNA in process solutions using high-performance hydrophobic interaction chromatography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Effects of fermentation strategy on the characteristics of plasmid DNA production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5alpha).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Fed-batch microbioreactor platform for scale down and analysis of a plasmid DNA production process.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

Comparison of growth, acetate production, and acetate inhibition of Escherichia coli strains in batch and fed-batch fermentations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.023

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2014.02.023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24598722%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference